49 Recruiting Psoriasis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Psoriasis
Related Conditions
Top Recruiting Psoriasis Studies
Deucravacitinib Adherence Study
📍 Wake Forest University Health Sciences Department of Dermatology — Winston-Salem, North Carolina
View Study & Checklist ➔An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects
📍 Bausch Site 003 — San Diego, California
View Study & Checklist ➔Psoriasis Longitudinal Assessment and Registry
📍 Clinical Research Facility — Birmingham, Alabama
View Study & Checklist ➔Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977
📍 UAB Department of Dermatology /ID# 252305 — Birmingham, Alabama
View Study & Checklist ➔Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
📍 Total Skin and Beauty Dermatology Center — Birmingham, Alabama
View Study & Checklist ➔Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
📍 CARE Site 42 — Calgary, Alberta
View Study & Checklist ➔A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
📍 Bristol-Meyers Squibb — Lawrenceville, New Jersey
View Study & Checklist ➔Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study)
📍 Wake Forest University Health Sciences — Winston-Salem, North Carolina
View Study & Checklist ➔Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
📍 Caja Costarricense del Seguro Social — San José, Provincia de San José
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Psoriasis Comorbidities at Hospital Calderón Guardia
📍 Caja Costarricense del Seguro Social — San José, Provincia de San José
View Study & Checklist ➔Assessing Psoriasis Treatment Outcomes
📍 Wake Forest University Health Sciences Department of Dermatology — Winston-Salem, North Carolina
View Study & Checklist ➔A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
📍 Local Institution — Waltham, Massachusetts
View Study & Checklist ➔Taltz in Combination With Enstilar for Psoriasis
📍 Psoriasis Treatment Center of Central New Jersey — East Windsor, New Jersey
View Study & Checklist ➔Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
📍 University of California, San Diego — La Jolla, California
View Study & Checklist ➔An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
📍 Elise Nelson — East Windsor, New Jersey
View Study & Checklist ➔Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
📍 University of California, Davis - Dermatology Department — Sacramento, California
View Study & Checklist ➔Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
📍 Psoriasis Treatment Center of Central New Jersey — East Windsor, New Jersey
View Study & Checklist ➔Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
📍 NuLine Clinical Trial Center — Pompano Beach, Florida
View Study & Checklist ➔A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
📍 Decentralized Study Coordinating Center — Englewood, New Jersey
View Study & Checklist ➔Regulation of Inflammatory Genes in Psoriasis
📍 The Kirklin Clinic — Birmingham, Alabama
View Study & Checklist ➔PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
📍 CorEvitas, LLC — Waltham, Massachusetts
View Study & Checklist ➔Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
📍 University Hospitals Cleveland Medical Center — Cleveland, Ohio
View Study & Checklist ➔ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
📍 Psoriasis Treatment Center of Central New Jersey — East Windsor, New Jersey
View Study & Checklist ➔Duobrii in Combination With Biologics
📍 Psoriasis Treatment Center of Central New Jersey — East Windsor, New Jersey
View Study & Checklist ➔A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
📍 Study Center — Birmingham, Alabama
View Study & Checklist ➔Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
📍 Kinetic Clinical Research — Anaheim, California
View Study & Checklist ➔PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
📍 CorEvitas, LLC — Waltham, Massachusetts
View Study & Checklist ➔A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
📍 University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
📍 Bausch Site 11 — Fountain Valley, California
View Study & Checklist ➔Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
📍 University Hospitals Cleveland Medical Center — Cleveland, Ohio
View Study & Checklist ➔A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
📍 Medical Dermatology Specialists — Phoenix, Arizona
View Study & Checklist ➔The CorEvitas Psoriasis (PSO) Registry
📍 Clinical Research Facility — Waltham, Massachusetts
View Study & Checklist ➔Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects
📍 Innovacion y Desarrollo de Estrategias en Salud — Mexico City,
View Study & Checklist ➔Multi-Center PAMPA Study
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔